Charles River Laboratories

Massachusetts
Pharmaceuticals Biotechnology and Life Sciences

Corporate Bias Rating

Expand Summary

Risk Level:

Rating - Danger
High Risk

Summary:

By complying with the HRC’s controversial demands, Charles River Laboratories increases the risk of dividing employees, alienating customers and harming shareholders. The company covers transgender-related medical costs for its employees and their children and provides specific sexual orientation and gender identity-based benefits. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Charles River uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. The company opposed various state and local legislation intended to protect parental rights, girls’ sports, bathroom facilities, and gendered spaces. For these reasons, Charles River receives a High Risk rating.

Shareholder Proposals

Expand Summary

Date
ESG Category
Proponent
Summary of ResolutionMgmt RecTotal Vote % in Favor
5/9/23SocialPETAReport on Non-Human Primate Use/WelfareAgainst35.80%
Generate Reports
Clear
Toast